Korean developer Dong-A has signed an exclusive licensing deal with Turkey’s Polifarma covering its darbepoetin biosimilar version of Aranesp/Nesp in Turkey, Brazil and Mexico.
Korean biosimilars developer Dong-A ST has signed a licensing deal with Turkey’s Polifarma offering exclusive rights to its Aranesp/Nesp (darbepoetin biosimilar) biosimilar, DA-3880, in Turkey, Brazil and Mexico.
Dong-A said the deal formed part of its efforts aimed at “building a foundation for expanding its biosimilar business through...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
